Shay Shemesh

918 total citations
24 papers, 578 citations indexed

About

Shay Shemesh is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Shay Shemesh has authored 24 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Shay Shemesh's work include Acute Myeloid Leukemia Research (2 papers), Airway Management and Intubation Techniques (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Shay Shemesh is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Airway Management and Intubation Techniques (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Shay Shemesh collaborates with scholars based in United States, Israel and Canada. Shay Shemesh's co-authors include Sharon Ovnat Tamir, Yahav Oron, Christopher Brooks, Naveen Pemmaraju, Tal Marom, Eunice S. Wang, Myles Wolf, Sumithira Vasu, Anthony S. Stein and Pablo E. Pérgola and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Shay Shemesh

23 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shay Shemesh United States 10 166 164 137 108 90 24 578
Patricia Moya Spain 14 66 0.4× 108 0.7× 29 0.2× 74 0.7× 81 0.9× 65 565
Daiki Nakagomi Japan 16 46 0.3× 105 0.6× 49 0.4× 104 1.0× 108 1.2× 61 906
Hector Mesa United States 12 148 0.9× 75 0.5× 26 0.2× 49 0.5× 30 0.3× 73 617
I. Koetter Germany 16 47 0.3× 149 0.9× 89 0.6× 37 0.3× 210 2.3× 28 844
Sylvie Daliphard France 12 97 0.6× 197 1.2× 105 0.8× 160 1.5× 90 1.0× 27 489
Ioannis Alexiou Greece 14 82 0.5× 73 0.4× 58 0.4× 15 0.1× 147 1.6× 23 681
S. Menon United Kingdom 7 50 0.3× 113 0.7× 49 0.4× 29 0.3× 86 1.0× 16 621
Mildred Wilson United States 7 112 0.7× 135 0.8× 30 0.2× 48 0.4× 52 0.6× 7 1.0k
S. Grootenboer‐Mignot France 14 36 0.2× 43 0.3× 47 0.3× 138 1.3× 220 2.4× 25 599
C. August Germany 12 80 0.5× 64 0.4× 25 0.2× 28 0.3× 56 0.6× 31 577

Countries citing papers authored by Shay Shemesh

Since Specialization
Citations

This map shows the geographic impact of Shay Shemesh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shay Shemesh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shay Shemesh more than expected).

Fields of papers citing papers by Shay Shemesh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shay Shemesh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shay Shemesh. The network helps show where Shay Shemesh may publish in the future.

Co-authorship network of co-authors of Shay Shemesh

This figure shows the co-authorship network connecting the top 25 collaborators of Shay Shemesh. A scholar is included among the top collaborators of Shay Shemesh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shay Shemesh. Shay Shemesh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pacey, Simon, Simon Rodney, Ruth Ruddle, et al.. (2024). Abstract CT111: Pharmacokinetic and pharmacodynamic evaluation of NXP800, a novel GCN2 activator, in a first in human clinical trial. Cancer Research. 84(7_Supplement). CT111–CT111. 1 indexed citations
2.
Banerji, Udai, Simon Pacey, Simon Rodney, et al.. (2023). Abstract B044: Results of a phase 1 dose escalation clinical trial of NXP800, a novel GCN2 activator, in patients with advanced or metastatic solid tumors. Molecular Cancer Therapeutics. 22(12_Supplement). B044–B044. 1 indexed citations
3.
Marom, Tal, et al.. (2020). Adult Otogenic Meningitis in the Pneumococcal Conjugated Vaccines Era. International Archives of Otorhinolaryngology. 24(2). e175–e181. 6 indexed citations
4.
Shushan, Sagit, Shay Shemesh, Omer J. Ungar, et al.. (2019). Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio among Patients with Vestibular Neuritis. ORL. 81(5-6). 304–308. 8 indexed citations
5.
Pemmaraju, Naveen, Haris Ali, Vikas Gupta, et al.. (2019). Results from ongoing phase 1/2 clinical trial of tagraxofusp (SL-401) in patients with intermediate or high risk relapsed/refractory myelofibrosis.. Journal of Clinical Oncology. 37(15_suppl). 7058–7058. 8 indexed citations
6.
Pemmaraju, Naveen, Andrew A. Lane, Kendra Sweet, et al.. (2019). Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm. New England Journal of Medicine. 380(17). 1628–1637. 242 indexed citations
7.
Pemmaraju, Naveen, Andrew A. Lane, Kendra Sweet, et al.. (2019). PS1063 RESULTS OF PIVOTAL PHASE 2 CLINICAL TRIAL OF TAGRAXOFUSP (SL‐401) IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN). HemaSphere. 3(S1). 481–481. 2 indexed citations
8.
Tamir, Sharon Ovnat, et al.. (2018). 30-Day Morbidity and Mortality Rates in Elderly Subjects Following Surgical Tracheostomy. Respiratory Care. 63(8). 1009–1015. 6 indexed citations
9.
Pemmaraju, Naveen, Vikas Gupta, Gary J. Schiller, et al.. (2018). Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis. Blood. 132(Supplement 1). 1773–1773. 9 indexed citations
10.
Marom, Tal, et al.. (2018). Adult acute rhinosinusitis guidelines worldwide: similarities and disparities. International Forum of Allergy & Rhinology. 8(8). 939–947. 6 indexed citations
11.
Patnaik, Mrinal M., Haris Ali, Vikas Gupta, et al.. (2018). Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Relapsed/Refractory Chronic Myelomonocytic Leukemia (CMML). Blood. 132(Supplement 1). 1821–1821. 13 indexed citations
12.
Tamir, Sharon Ovnat, et al.. (2018). Fish Bone Foreign Body: The Role of Imaging. International Archives of Otorhinolaryngology. 23(1). 110–115. 29 indexed citations
13.
Barve, Minal, E. Gabriela Chiorean, Patricia LoRusso, et al.. (2018). Interim results from a phase 1 trial of SL-801, a novel XPO-1 inhibitor, in patients with advanced solid tumors.. Journal of Clinical Oncology. 36(15_suppl). 2560–2560. 1 indexed citations
14.
Oron, Yahav, Shay Shemesh, Sagit Shushan, et al.. (2017). Cardiovascular Risk Factors Among Patients With Vestibular Neuritis. Annals of Otology Rhinology & Laryngology. 126(8). 597–601. 41 indexed citations
15.
Tamir, Sharon Ovnat, Shay Shemesh, Yahav Oron, & Tal Marom. (2016). Acute otitis media guidelines in selected developed and developing countries: uniformity and diversity. Archives of Disease in Childhood. 102(5). 450–457. 48 indexed citations
16.
Pemmaraju, Naveen, Andrew A. Lane, Kendra Sweet, et al.. (2016). Results from phase 2 registration trial of SL-401 in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): Lead-in completed, expansion stage ongoing.. Journal of Clinical Oncology. 34(15_suppl). 7006–7006. 11 indexed citations
17.
Htut, Myo, Cristina Gasparetto, Jeffrey A. Zonder, et al.. (2016). Results from Ongoing Phase 1/2 Trial of SL-401 in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma. Blood. 128(22). 5696–5696. 8 indexed citations
18.
Shemesh, Shay, Tal Marom, Hananya Vaknine, & Sharon Ovnat Tamir. (2015). Neisseria flavescens Infection in Atypical Multiple Vallecular Cysts. Indian Journal of Otolaryngology and Head & Neck Surgery. 71(S1). 11–13. 1 indexed citations
19.
Block, Geoffrey A., Steven Fishbane, Mariano Rodríguez, et al.. (2014). A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5. American Journal of Kidney Diseases. 65(5). 728–736. 109 indexed citations
20.
Grosskopf, Itamar, Aviv Shaish, Arnon Afek, et al.. (2012). Apolipoprotein A–V modulates multiple atherogenic mechanisms in a mouse model of disturbed clearance of triglyceride-rich lipoproteins. Atherosclerosis. 224(1). 75–83. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia Moya Breakdown of academic impact, for papers by Daiki Nakagomi Breakdown of academic impact, for papers by Hector Mesa Breakdown of academic impact, for papers by I. Koetter Breakdown of academic impact, for papers by Sylvie Daliphard Breakdown of academic impact, for papers by Ioannis Alexiou Breakdown of academic impact, for papers by S. Menon Breakdown of academic impact, for papers by Mildred Wilson Breakdown of academic impact, for papers by S. Grootenboer‐Mignot Breakdown of academic impact, for papers by C. August
Rankless by CCL
2026